Treatment with cannabidiol (CBD) reduced inflammation and lessened damaging oxidative stress in a rat model of pulmonary hypertension (PH),…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has approved Tyvaso DPI, a dry powder, inhaled formulation of treprostinil, to improve…
Even with modern advances in treatments, many people in the U.S. with pulmonary arterial hypertension (PAH) are at an…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Combining measures of symptom severity, physical function, and heart health can help predict survival outcomes in pulmonary arterial hypertension…
People with pulmonary arterial hypertension of unknown cause, or idiopathic disease, who are older, male, or of low socioeconomic…
A new company spin-out from the University of Bath, in the U.K., is developing machine learning technologies that aim to…
Pulmonary hypertension (PH) has a profound impact on the identity and sexuality of the women who live with the…
Hospital-based administrative data can be used to identify patients with pulmonary hypertension (PH) in medical records, according to a…
Among people who have had a heart attack, those with pulmonary hypertension (PH) are at high risk of heart…
Measuring levels of protein sLR11 in the blood could be useful in testing for pulmonary hypertension (PH) in people…
The use of imaging to evaluate the right side of the heart could be useful for non-invasively diagnosing and monitoring…